nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—kidney cancer	0.402	0.685	CbGaD
Triamcinolone—PTGS2—kidney cancer	0.185	0.315	CbGaD
Triamcinolone—CYP3A4—Everolimus—kidney cancer	0.0469	0.293	CbGbCtD
Triamcinolone—CYP3A4—Temsirolimus—kidney cancer	0.0317	0.198	CbGbCtD
Triamcinolone—CYP3A4—Pazopanib—kidney cancer	0.0166	0.104	CbGbCtD
Triamcinolone—CYP3A4—Erlotinib—kidney cancer	0.0119	0.0741	CbGbCtD
Triamcinolone—CYP3A4—Paclitaxel—kidney cancer	0.0109	0.0679	CbGbCtD
Triamcinolone—CYP3A4—Sorafenib—kidney cancer	0.00965	0.0603	CbGbCtD
Triamcinolone—CYP3A4—Vinblastine—kidney cancer	0.00953	0.0595	CbGbCtD
Triamcinolone—CYP3A4—Vincristine—kidney cancer	0.00937	0.0585	CbGbCtD
Triamcinolone—CYP3A4—Sunitinib—kidney cancer	0.00782	0.0488	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—kidney cancer	0.00586	0.0366	CbGbCtD
Triamcinolone—PTGS2—nephron—kidney cancer	0.00308	0.138	CbGeAlD
Triamcinolone—NR3C1—urine—kidney cancer	0.00286	0.128	CbGeAlD
Triamcinolone—CYP3A4—urine—kidney cancer	0.00216	0.0967	CbGeAlD
Triamcinolone—SERPINA6—nephron tubule—kidney cancer	0.00176	0.0786	CbGeAlD
Triamcinolone—SERPINA6—renal system—kidney cancer	0.0016	0.0714	CbGeAlD
Triamcinolone—SERPINA6—kidney—kidney cancer	0.00154	0.069	CbGeAlD
Triamcinolone—SERPINA6—cortex of kidney—kidney cancer	0.0015	0.0672	CbGeAlD
Triamcinolone—Amcinonide—ANXA1—kidney cancer	0.00137	0.388	CrCbGaD
Triamcinolone—BCHE—nephron tubule—kidney cancer	0.000864	0.0387	CbGeAlD
Triamcinolone—NR3C1—nephron tubule—kidney cancer	0.000769	0.0344	CbGeAlD
Triamcinolone—BCHE—cardiac atrium—kidney cancer	0.000703	0.0315	CbGeAlD
Triamcinolone—NR3C1—renal system—kidney cancer	0.000699	0.0313	CbGeAlD
Triamcinolone—NR3C1—kidney—kidney cancer	0.000676	0.0302	CbGeAlD
Triamcinolone—NR3C1—cortex of kidney—kidney cancer	0.000658	0.0295	CbGeAlD
Triamcinolone—NR3C1—gonad—kidney cancer	0.000627	0.0281	CbGeAlD
Triamcinolone—NR3C1—cardiac atrium—kidney cancer	0.000626	0.028	CbGeAlD
Triamcinolone—PTGS2—renal system—kidney cancer	0.000605	0.0271	CbGeAlD
Triamcinolone—PTGS2—kidney—kidney cancer	0.000585	0.0262	CbGeAlD
Triamcinolone—Hydrocortisone—ANXA1—kidney cancer	0.000576	0.164	CrCbGaD
Triamcinolone—CYP3A4—renal system—kidney cancer	0.000529	0.0237	CbGeAlD
Triamcinolone—CYP3A4—kidney—kidney cancer	0.000511	0.0229	CbGeAlD
Triamcinolone—Dexamethasone—ANXA1—kidney cancer	0.000429	0.122	CrCbGaD
Triamcinolone—Clobetasol propionate—CYP1A1—kidney cancer	0.000247	0.07	CrCbGaD
Triamcinolone—Fluticasone furoate—ABCB1—kidney cancer	0.000153	0.0435	CrCbGaD
Triamcinolone—Fatigue—Sunitinib—kidney cancer	0.000147	0.000773	CcSEcCtD
Triamcinolone—Asthenia—Everolimus—kidney cancer	0.000146	0.00077	CcSEcCtD
Triamcinolone—Cough—Gemcitabine—kidney cancer	0.000146	0.000769	CcSEcCtD
Triamcinolone—Pain—Sunitinib—kidney cancer	0.000145	0.000767	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Capecitabine—kidney cancer	0.000145	0.000764	CcSEcCtD
Triamcinolone—Hypertension—Gemcitabine—kidney cancer	0.000144	0.000761	CcSEcCtD
Triamcinolone—Myocardial infarction—Capecitabine—kidney cancer	0.000144	0.00076	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Capecitabine—kidney cancer	0.000144	0.00076	CcSEcCtD
Triamcinolone—Pruritus—Everolimus—kidney cancer	0.000144	0.00076	CcSEcCtD
Triamcinolone—Oedema—Vincristine—kidney cancer	0.000144	0.000759	CcSEcCtD
Triamcinolone—Anaphylactic shock—Vincristine—kidney cancer	0.000144	0.000759	CcSEcCtD
Triamcinolone—Arrhythmia—Paclitaxel—kidney cancer	0.000144	0.000758	CcSEcCtD
Triamcinolone—Infection—Vincristine—kidney cancer	0.000143	0.000754	CcSEcCtD
Triamcinolone—Conjunctivitis—Capecitabine—kidney cancer	0.000143	0.000754	CcSEcCtD
Triamcinolone—Myalgia—Gemcitabine—kidney cancer	0.000142	0.000751	CcSEcCtD
Triamcinolone—Thrombophlebitis—Doxorubicin—kidney cancer	0.000142	0.000749	CcSEcCtD
Triamcinolone—Diabetes mellitus—Doxorubicin—kidney cancer	0.000141	0.000745	CcSEcCtD
Triamcinolone—Asthenia—Erlotinib—kidney cancer	0.000141	0.000743	CcSEcCtD
Triamcinolone—Discomfort—Gemcitabine—kidney cancer	0.000141	0.000742	CcSEcCtD
Triamcinolone—Urticaria—Sorafenib—kidney cancer	0.00014	0.00074	CcSEcCtD
Triamcinolone—Erythema—Paclitaxel—kidney cancer	0.00014	0.000738	CcSEcCtD
Triamcinolone—Body temperature increased—Sorafenib—kidney cancer	0.00014	0.000737	CcSEcCtD
Triamcinolone—Hyperhidrosis—Vincristine—kidney cancer	0.000139	0.000733	CcSEcCtD
Triamcinolone—Pruritus—Erlotinib—kidney cancer	0.000139	0.000733	CcSEcCtD
Triamcinolone—Fatigue—Dactinomycin—kidney cancer	0.000139	0.000732	CcSEcCtD
Triamcinolone—Epistaxis—Capecitabine—kidney cancer	0.000139	0.000731	CcSEcCtD
Triamcinolone—Pain—Dactinomycin—kidney cancer	0.000138	0.000726	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—kidney cancer	0.000137	0.000725	CcSEcCtD
Triamcinolone—Dysgeusia—Paclitaxel—kidney cancer	0.000137	0.000723	CcSEcCtD
Triamcinolone—Oedema—Gemcitabine—kidney cancer	0.000136	0.00072	CcSEcCtD
Triamcinolone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000136	0.00072	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000136	0.000715	CcSEcCtD
Triamcinolone—Infection—Gemcitabine—kidney cancer	0.000135	0.000715	CcSEcCtD
Triamcinolone—Back pain—Paclitaxel—kidney cancer	0.000135	0.000714	CcSEcCtD
Triamcinolone—Dizziness—Vinblastine—kidney cancer	0.000135	0.000713	CcSEcCtD
Triamcinolone—Dizziness—Everolimus—kidney cancer	0.000135	0.00071	CcSEcCtD
Triamcinolone—Body temperature increased—Sunitinib—kidney cancer	0.000134	0.000709	CcSEcCtD
Triamcinolone—Bradycardia—Capecitabine—kidney cancer	0.000134	0.000708	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—kidney cancer	0.000133	0.0007	CcSEcCtD
Triamcinolone—Haemoglobin—Capecitabine—kidney cancer	0.000133	0.000699	CcSEcCtD
Triamcinolone—Rhinitis—Capecitabine—kidney cancer	0.000132	0.000698	CcSEcCtD
Triamcinolone—Haemorrhage—Capecitabine—kidney cancer	0.000132	0.000696	CcSEcCtD
Triamcinolone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000132	0.000696	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000131	0.000691	CcSEcCtD
Triamcinolone—Pharyngitis—Capecitabine—kidney cancer	0.000131	0.000691	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—kidney cancer	0.000131	0.00069	CcSEcCtD
Triamcinolone—Hypersensitivity—Sorafenib—kidney cancer	0.00013	0.000687	CcSEcCtD
Triamcinolone—Insomnia—Vincristine—kidney cancer	0.00013	0.000686	CcSEcCtD
Triamcinolone—Vomiting—Vinblastine—kidney cancer	0.00013	0.000685	CcSEcCtD
Triamcinolone—Dizziness—Erlotinib—kidney cancer	0.00013	0.000685	CcSEcCtD
Triamcinolone—Ill-defined disorder—Paclitaxel—kidney cancer	0.00013	0.000685	CcSEcCtD
Triamcinolone—Vomiting—Everolimus—kidney cancer	0.000129	0.000683	CcSEcCtD
Triamcinolone—Paraesthesia—Vincristine—kidney cancer	0.000129	0.000681	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—kidney cancer	0.000129	0.000678	CcSEcCtD
Triamcinolone—Rash—Everolimus—kidney cancer	0.000128	0.000677	CcSEcCtD
Triamcinolone—Dermatitis—Everolimus—kidney cancer	0.000128	0.000676	CcSEcCtD
Triamcinolone—Headache—Vinblastine—kidney cancer	0.000128	0.000675	CcSEcCtD
Triamcinolone—Angioedema—Paclitaxel—kidney cancer	0.000128	0.000675	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—kidney cancer	0.000128	0.000673	CcSEcCtD
Triamcinolone—Headache—Everolimus—kidney cancer	0.000127	0.000673	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—kidney cancer	0.000127	0.000671	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000127	0.00067	CcSEcCtD
Triamcinolone—Asthenia—Sorafenib—kidney cancer	0.000127	0.000669	CcSEcCtD
Triamcinolone—Malaise—Paclitaxel—kidney cancer	0.000126	0.000666	CcSEcCtD
Triamcinolone—Vertigo—Paclitaxel—kidney cancer	0.000126	0.000663	CcSEcCtD
Triamcinolone—Syncope—Paclitaxel—kidney cancer	0.000125	0.000662	CcSEcCtD
Triamcinolone—Hypersensitivity—Sunitinib—kidney cancer	0.000125	0.000661	CcSEcCtD
Triamcinolone—Pruritus—Sorafenib—kidney cancer	0.000125	0.000659	CcSEcCtD
Triamcinolone—Vomiting—Erlotinib—kidney cancer	0.000125	0.000659	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000124	0.000656	CcSEcCtD
Triamcinolone—Fatigue—Vincristine—kidney cancer	0.000124	0.000654	CcSEcCtD
Triamcinolone—Rash—Erlotinib—kidney cancer	0.000124	0.000653	CcSEcCtD
Triamcinolone—Dermatitis—Erlotinib—kidney cancer	0.000124	0.000653	CcSEcCtD
Triamcinolone—Insomnia—Gemcitabine—kidney cancer	0.000123	0.000651	CcSEcCtD
Triamcinolone—Headache—Erlotinib—kidney cancer	0.000123	0.000649	CcSEcCtD
Triamcinolone—Loss of consciousness—Paclitaxel—kidney cancer	0.000123	0.000649	CcSEcCtD
Triamcinolone—Pain—Vincristine—kidney cancer	0.000123	0.000649	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—kidney cancer	0.000123	0.000648	CcSEcCtD
Triamcinolone—Paraesthesia—Gemcitabine—kidney cancer	0.000122	0.000646	CcSEcCtD
Triamcinolone—Cough—Paclitaxel—kidney cancer	0.000122	0.000644	CcSEcCtD
Triamcinolone—Methylprednisolone—ABCB1—kidney cancer	0.000122	0.0347	CrCbGaD
Triamcinolone—Asthenia—Sunitinib—kidney cancer	0.000122	0.000643	CcSEcCtD
Triamcinolone—Dyspnoea—Gemcitabine—kidney cancer	0.000122	0.000642	CcSEcCtD
Triamcinolone—Nausea—Vinblastine—kidney cancer	0.000121	0.00064	CcSEcCtD
Triamcinolone—Convulsion—Paclitaxel—kidney cancer	0.000121	0.00064	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—kidney cancer	0.000121	0.000638	CcSEcCtD
Triamcinolone—Nausea—Everolimus—kidney cancer	0.000121	0.000638	CcSEcCtD
Triamcinolone—Hypertension—Paclitaxel—kidney cancer	0.000121	0.000637	CcSEcCtD
Triamcinolone—Pruritus—Sunitinib—kidney cancer	0.00012	0.000634	CcSEcCtD
Triamcinolone—Myalgia—Paclitaxel—kidney cancer	0.000119	0.000628	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—kidney cancer	0.000119	0.000626	CcSEcCtD
Triamcinolone—Arrhythmia—Capecitabine—kidney cancer	0.000118	0.000622	CcSEcCtD
Triamcinolone—Discomfort—Paclitaxel—kidney cancer	0.000118	0.000621	CcSEcCtD
Triamcinolone—Fatigue—Gemcitabine—kidney cancer	0.000118	0.00062	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—kidney cancer	0.000117	0.000617	CcSEcCtD
Triamcinolone—Dizziness—Sorafenib—kidney cancer	0.000117	0.000616	CcSEcCtD
Triamcinolone—Pain—Gemcitabine—kidney cancer	0.000117	0.000615	CcSEcCtD
Triamcinolone—Nausea—Erlotinib—kidney cancer	0.000117	0.000615	CcSEcCtD
Triamcinolone—Dry mouth—Paclitaxel—kidney cancer	0.000116	0.000615	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—kidney cancer	0.000116	0.000614	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—kidney cancer	0.000115	0.000609	CcSEcCtD
Triamcinolone—Erythema—Capecitabine—kidney cancer	0.000115	0.000606	CcSEcCtD
Triamcinolone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000114	0.000602	CcSEcCtD
Triamcinolone—Oedema—Paclitaxel—kidney cancer	0.000114	0.000602	CcSEcCtD
Triamcinolone—Body temperature increased—Vincristine—kidney cancer	0.000114	0.0006	CcSEcCtD
Triamcinolone—Infection—Paclitaxel—kidney cancer	0.000113	0.000599	CcSEcCtD
Triamcinolone—Dysgeusia—Capecitabine—kidney cancer	0.000112	0.000593	CcSEcCtD
Triamcinolone—Dizziness—Sunitinib—kidney cancer	0.000112	0.000593	CcSEcCtD
Triamcinolone—Feeling abnormal—Gemcitabine—kidney cancer	0.000112	0.000593	CcSEcCtD
Triamcinolone—Shock—Paclitaxel—kidney cancer	0.000112	0.000593	CcSEcCtD
Triamcinolone—Vomiting—Sorafenib—kidney cancer	0.000112	0.000593	CcSEcCtD
Triamcinolone—Tachycardia—Paclitaxel—kidney cancer	0.000111	0.000588	CcSEcCtD
Triamcinolone—Rash—Sorafenib—kidney cancer	0.000111	0.000588	CcSEcCtD
Triamcinolone—Dermatitis—Sorafenib—kidney cancer	0.000111	0.000587	CcSEcCtD
Triamcinolone—Back pain—Capecitabine—kidney cancer	0.000111	0.000586	CcSEcCtD
Triamcinolone—Headache—Sorafenib—kidney cancer	0.000111	0.000584	CcSEcCtD
Triamcinolone—Hyperhidrosis—Paclitaxel—kidney cancer	0.00011	0.000582	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—kidney cancer	0.000108	0.000572	CcSEcCtD
Triamcinolone—Vomiting—Sunitinib—kidney cancer	0.000108	0.00057	CcSEcCtD
Triamcinolone—Body temperature increased—Gemcitabine—kidney cancer	0.000108	0.000569	CcSEcCtD
Triamcinolone—Rash—Sunitinib—kidney cancer	0.000107	0.000565	CcSEcCtD
Triamcinolone—Dermatitis—Sunitinib—kidney cancer	0.000107	0.000565	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—kidney cancer	0.000107	0.000564	CcSEcCtD
Triamcinolone—Ill-defined disorder—Capecitabine—kidney cancer	0.000107	0.000562	CcSEcCtD
Triamcinolone—Headache—Sunitinib—kidney cancer	0.000106	0.000562	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—kidney cancer	0.000106	0.00056	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—kidney cancer	0.000106	0.00056	CcSEcCtD
Triamcinolone—Hypersensitivity—Vincristine—kidney cancer	0.000106	0.000559	CcSEcCtD
Triamcinolone—Nausea—Sorafenib—kidney cancer	0.000105	0.000554	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—kidney cancer	0.000104	0.000549	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000104	0.000549	CcSEcCtD
Triamcinolone—Malaise—Capecitabine—kidney cancer	0.000104	0.000546	CcSEcCtD
Triamcinolone—Insomnia—Paclitaxel—kidney cancer	0.000103	0.000545	CcSEcCtD
Triamcinolone—Vertigo—Capecitabine—kidney cancer	0.000103	0.000544	CcSEcCtD
Triamcinolone—Asthenia—Vincristine—kidney cancer	0.000103	0.000544	CcSEcCtD
Triamcinolone—Syncope—Capecitabine—kidney cancer	0.000103	0.000543	CcSEcCtD
Triamcinolone—Paraesthesia—Paclitaxel—kidney cancer	0.000103	0.000541	CcSEcCtD
Triamcinolone—Vomiting—Dactinomycin—kidney cancer	0.000102	0.00054	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—kidney cancer	0.000102	0.000539	CcSEcCtD
Triamcinolone—Dyspnoea—Paclitaxel—kidney cancer	0.000102	0.000537	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—kidney cancer	0.000101	0.000535	CcSEcCtD
Triamcinolone—Nausea—Sunitinib—kidney cancer	0.000101	0.000533	CcSEcCtD
Triamcinolone—Loss of consciousness—Capecitabine—kidney cancer	0.000101	0.000532	CcSEcCtD
Triamcinolone—Dyspepsia—Paclitaxel—kidney cancer	0.000101	0.00053	CcSEcCtD
Triamcinolone—Cough—Capecitabine—kidney cancer	0.0001	0.000529	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—kidney cancer	9.91e-05	0.0282	CrCbGaD
Triamcinolone—Hypertension—Capecitabine—kidney cancer	9.91e-05	0.000523	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.87e-05	0.000521	CcSEcCtD
Triamcinolone—Fatigue—Paclitaxel—kidney cancer	9.84e-05	0.000519	CcSEcCtD
Triamcinolone—Asthenia—Gemcitabine—kidney cancer	9.78e-05	0.000516	CcSEcCtD
Triamcinolone—Myalgia—Capecitabine—kidney cancer	9.77e-05	0.000516	CcSEcCtD
Triamcinolone—Pain—Paclitaxel—kidney cancer	9.76e-05	0.000515	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—kidney cancer	9.67e-05	0.00051	CcSEcCtD
Triamcinolone—Discomfort—Capecitabine—kidney cancer	9.66e-05	0.00051	CcSEcCtD
Triamcinolone—Pruritus—Gemcitabine—kidney cancer	9.65e-05	0.000509	CcSEcCtD
Triamcinolone—Dry mouth—Capecitabine—kidney cancer	9.56e-05	0.000504	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—kidney cancer	9.56e-05	0.000504	CcSEcCtD
Triamcinolone—Dizziness—Vincristine—kidney cancer	9.51e-05	0.000502	CcSEcCtD
Triamcinolone—Feeling abnormal—Paclitaxel—kidney cancer	9.41e-05	0.000496	CcSEcCtD
Triamcinolone—Oedema—Capecitabine—kidney cancer	9.37e-05	0.000494	CcSEcCtD
Triamcinolone—Prednisone—ABCB1—kidney cancer	9.33e-05	0.0265	CrCbGaD
Triamcinolone—Infection—Capecitabine—kidney cancer	9.31e-05	0.000491	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—kidney cancer	9.28e-05	0.00049	CcSEcCtD
Triamcinolone—Dexamethasone—CYP1A1—kidney cancer	9.23e-05	0.0262	CrCbGaD
Triamcinolone—Shock—Capecitabine—kidney cancer	9.22e-05	0.000486	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—kidney cancer	9.21e-05	0.000486	CcSEcCtD
Triamcinolone—Tachycardia—Capecitabine—kidney cancer	9.15e-05	0.000483	CcSEcCtD
Triamcinolone—Vomiting—Vincristine—kidney cancer	9.14e-05	0.000482	CcSEcCtD
Triamcinolone—Urticaria—Paclitaxel—kidney cancer	9.07e-05	0.000479	CcSEcCtD
Triamcinolone—Rash—Vincristine—kidney cancer	9.06e-05	0.000478	CcSEcCtD
Triamcinolone—Hyperhidrosis—Capecitabine—kidney cancer	9.06e-05	0.000478	CcSEcCtD
Triamcinolone—Dermatitis—Vincristine—kidney cancer	9.06e-05	0.000478	CcSEcCtD
Triamcinolone—Body temperature increased—Paclitaxel—kidney cancer	9.03e-05	0.000476	CcSEcCtD
Triamcinolone—Headache—Vincristine—kidney cancer	9.01e-05	0.000475	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—kidney cancer	8.93e-05	0.000471	CcSEcCtD
Triamcinolone—Vomiting—Gemcitabine—kidney cancer	8.67e-05	0.000458	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—kidney cancer	8.65e-05	0.000457	CcSEcCtD
Triamcinolone—Prednisolone—ABCB1—kidney cancer	8.6e-05	0.0244	CrCbGaD
Triamcinolone—Rash—Gemcitabine—kidney cancer	8.6e-05	0.000454	CcSEcCtD
Triamcinolone—Dermatitis—Gemcitabine—kidney cancer	8.59e-05	0.000453	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—kidney cancer	8.54e-05	0.000451	CcSEcCtD
Triamcinolone—Headache—Gemcitabine—kidney cancer	8.54e-05	0.000451	CcSEcCtD
Triamcinolone—Nausea—Vincristine—kidney cancer	8.54e-05	0.000451	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.54e-05	0.00045	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—kidney cancer	8.52e-05	0.00045	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—kidney cancer	8.5e-05	0.000449	CcSEcCtD
Triamcinolone—Insomnia—Capecitabine—kidney cancer	8.48e-05	0.000447	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—kidney cancer	8.44e-05	0.000445	CcSEcCtD
Triamcinolone—Betamethasone—ABCB1—kidney cancer	8.43e-05	0.0239	CrCbGaD
Triamcinolone—Paraesthesia—Capecitabine—kidney cancer	8.41e-05	0.000444	CcSEcCtD
Triamcinolone—Hypersensitivity—Paclitaxel—kidney cancer	8.41e-05	0.000444	CcSEcCtD
Triamcinolone—Dyspnoea—Capecitabine—kidney cancer	8.35e-05	0.000441	CcSEcCtD
Triamcinolone—Dyspepsia—Capecitabine—kidney cancer	8.25e-05	0.000435	CcSEcCtD
Triamcinolone—Asthenia—Paclitaxel—kidney cancer	8.19e-05	0.000432	CcSEcCtD
Triamcinolone—Nausea—Gemcitabine—kidney cancer	8.1e-05	0.000427	CcSEcCtD
Triamcinolone—Fatigue—Capecitabine—kidney cancer	8.08e-05	0.000426	CcSEcCtD
Triamcinolone—Pruritus—Paclitaxel—kidney cancer	8.08e-05	0.000426	CcSEcCtD
Triamcinolone—Pain—Capecitabine—kidney cancer	8.01e-05	0.000423	CcSEcCtD
Triamcinolone—Feeling abnormal—Capecitabine—kidney cancer	7.72e-05	0.000407	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—kidney cancer	7.59e-05	0.000401	CcSEcCtD
Triamcinolone—Dizziness—Paclitaxel—kidney cancer	7.55e-05	0.000398	CcSEcCtD
Triamcinolone—Urticaria—Capecitabine—kidney cancer	7.44e-05	0.000393	CcSEcCtD
Triamcinolone—Body temperature increased—Capecitabine—kidney cancer	7.41e-05	0.000391	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—kidney cancer	7.4e-05	0.00039	CcSEcCtD
Triamcinolone—Vomiting—Paclitaxel—kidney cancer	7.26e-05	0.000383	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—kidney cancer	7.25e-05	0.000382	CcSEcCtD
Triamcinolone—Rash—Paclitaxel—kidney cancer	7.2e-05	0.00038	CcSEcCtD
Triamcinolone—Dermatitis—Paclitaxel—kidney cancer	7.19e-05	0.00038	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—kidney cancer	7.16e-05	0.000378	CcSEcCtD
Triamcinolone—Headache—Paclitaxel—kidney cancer	7.15e-05	0.000377	CcSEcCtD
Triamcinolone—Hypersensitivity—Capecitabine—kidney cancer	6.9e-05	0.000364	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—kidney cancer	6.87e-05	0.000362	CcSEcCtD
Triamcinolone—Nausea—Paclitaxel—kidney cancer	6.78e-05	0.000358	CcSEcCtD
Triamcinolone—Asthenia—Capecitabine—kidney cancer	6.72e-05	0.000355	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—kidney cancer	6.67e-05	0.000352	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—kidney cancer	6.65e-05	0.000351	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—kidney cancer	6.64e-05	0.00035	CcSEcCtD
Triamcinolone—Pruritus—Capecitabine—kidney cancer	6.63e-05	0.00035	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—EIF5B—kidney cancer	6.61e-05	0.00177	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	6.6e-05	0.00177	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	6.59e-05	0.00177	CbGpPWpGaD
Triamcinolone—Hydrocortisone—ABCB1—kidney cancer	6.58e-05	0.0187	CrCbGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.54e-05	0.00175	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.54e-05	0.00175	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	6.53e-05	0.00175	CbGpPWpGaD
Triamcinolone—Loss of consciousness—Doxorubicin—kidney cancer	6.5e-05	0.000343	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—kidney cancer	6.46e-05	0.000341	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	6.45e-05	0.00173	CbGpPWpGaD
Triamcinolone—Convulsion—Doxorubicin—kidney cancer	6.41e-05	0.000338	CcSEcCtD
Triamcinolone—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.41e-05	0.00172	CbGpPWpGaD
Triamcinolone—Hypertension—Doxorubicin—kidney cancer	6.39e-05	0.000337	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	6.31e-05	0.00169	CbGpPWpGaD
Triamcinolone—Myalgia—Doxorubicin—kidney cancer	6.3e-05	0.000332	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—kidney cancer	6.23e-05	0.000328	CcSEcCtD
Triamcinolone—Dizziness—Capecitabine—kidney cancer	6.2e-05	0.000327	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—kidney cancer	6.16e-05	0.000325	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.12e-05	0.00164	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	6.08e-05	0.00163	CbGpPWpGaD
Triamcinolone—Oedema—Doxorubicin—kidney cancer	6.04e-05	0.000319	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—kidney cancer	6.04e-05	0.000319	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—kidney cancer	6e-05	0.000317	CcSEcCtD
Triamcinolone—Vomiting—Capecitabine—kidney cancer	5.96e-05	0.000314	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	5.96e-05	0.0016	CbGpPWpGaD
Triamcinolone—Shock—Doxorubicin—kidney cancer	5.94e-05	0.000314	CcSEcCtD
Triamcinolone—Rash—Capecitabine—kidney cancer	5.91e-05	0.000312	CcSEcCtD
Triamcinolone—Dermatitis—Capecitabine—kidney cancer	5.9e-05	0.000311	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—kidney cancer	5.9e-05	0.000311	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	5.88e-05	0.00158	CbGpPWpGaD
Triamcinolone—Headache—Capecitabine—kidney cancer	5.87e-05	0.00031	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—kidney cancer	5.84e-05	0.000308	CcSEcCtD
Triamcinolone—Dexamethasone—PTGS2—kidney cancer	5.77e-05	0.0164	CrCbGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.67e-05	0.00152	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PDHB—kidney cancer	5.66e-05	0.00152	CbGpPWpGaD
Triamcinolone—Nausea—Capecitabine—kidney cancer	5.57e-05	0.000294	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	5.53e-05	0.00148	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	5.51e-05	0.00148	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.5e-05	0.00029	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—kidney cancer	5.46e-05	0.000288	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	5.45e-05	0.00146	CbGpPWpGaD
Triamcinolone—Paraesthesia—Doxorubicin—kidney cancer	5.42e-05	0.000286	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—MME—kidney cancer	5.42e-05	0.00145	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	5.41e-05	0.00145	CbGpPWpGaD
Triamcinolone—Dyspnoea—Doxorubicin—kidney cancer	5.39e-05	0.000284	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.37e-05	0.00144	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.32e-05	0.00143	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CCBL1—kidney cancer	5.32e-05	0.00143	CbGpPWpGaD
Triamcinolone—Dyspepsia—Doxorubicin—kidney cancer	5.32e-05	0.000281	CcSEcCtD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.28e-05	0.00142	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	5.24e-05	0.00141	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.21e-05	0.0014	CbGpPWpGaD
Triamcinolone—Fatigue—Doxorubicin—kidney cancer	5.21e-05	0.000275	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	5.2e-05	0.0014	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.2e-05	0.0014	CbGpPWpGaD
Triamcinolone—Pain—Doxorubicin—kidney cancer	5.17e-05	0.000273	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—RPL14—kidney cancer	5.04e-05	0.00135	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—HSPD1—kidney cancer	5.04e-05	0.00135	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	4.99e-05	0.00134	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Doxorubicin—kidney cancer	4.98e-05	0.000263	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	4.96e-05	0.00133	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	4.94e-05	0.00132	CbGpPWpGaD
Triamcinolone—Dexamethasone—ABCB1—kidney cancer	4.9e-05	0.0139	CrCbGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.81e-05	0.00129	CbGpPWpGaD
Triamcinolone—Urticaria—Doxorubicin—kidney cancer	4.8e-05	0.000253	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—kidney cancer	4.77e-05	0.000252	CcSEcCtD
Triamcinolone—BCHE—Phospholipid metabolism—PTEN—kidney cancer	4.68e-05	0.00126	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPAT—kidney cancer	4.61e-05	0.00124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GLIPR1—kidney cancer	4.61e-05	0.00124	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ACY1—kidney cancer	4.58e-05	0.00123	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CTNNB1—kidney cancer	4.57e-05	0.00123	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.55e-05	0.00122	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.51e-05	0.00121	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Doxorubicin—kidney cancer	4.45e-05	0.000235	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	4.4e-05	0.00118	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CCBL1—kidney cancer	4.37e-05	0.00117	CbGpPWpGaD
Triamcinolone—Asthenia—Doxorubicin—kidney cancer	4.33e-05	0.000229	CcSEcCtD
Triamcinolone—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	4.29e-05	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APRT—kidney cancer	4.29e-05	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—FH—kidney cancer	4.29e-05	0.00115	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.28e-05	0.00115	CbGpPWpGaD
Triamcinolone—Pruritus—Doxorubicin—kidney cancer	4.27e-05	0.000225	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—EEF2—kidney cancer	4.26e-05	0.00114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACHE—kidney cancer	4.16e-05	0.00112	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	4.12e-05	0.00111	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	4.11e-05	0.0011	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TET2—kidney cancer	4.08e-05	0.0011	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPC3—kidney cancer	4.03e-05	0.00108	CbGpPWpGaD
Triamcinolone—Dizziness—Doxorubicin—kidney cancer	3.99e-05	0.000211	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	3.98e-05	0.00107	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	3.98e-05	0.00107	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	3.96e-05	0.00106	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PAX6—kidney cancer	3.96e-05	0.00106	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AMER1—kidney cancer	3.95e-05	0.00106	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.95e-05	0.00106	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.94e-05	0.00106	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTSD—kidney cancer	3.93e-05	0.00106	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CA2—kidney cancer	3.92e-05	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.91e-05	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PDHB—kidney cancer	3.89e-05	0.00104	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL2—kidney cancer	3.88e-05	0.00104	CbGpPWpGaD
Triamcinolone—Vomiting—Doxorubicin—kidney cancer	3.84e-05	0.000203	CcSEcCtD
Triamcinolone—BCHE—Metabolism—ALAD—kidney cancer	3.82e-05	0.00103	CbGpPWpGaD
Triamcinolone—Rash—Doxorubicin—kidney cancer	3.81e-05	0.000201	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—kidney cancer	3.8e-05	0.000201	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—kidney cancer	3.78e-05	0.0002	CcSEcCtD
Triamcinolone—BCHE—Neuronal System—BRAF—kidney cancer	3.78e-05	0.00101	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	3.78e-05	0.00101	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.77e-05	0.00101	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.75e-05	0.00101	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TCEB1—kidney cancer	3.73e-05	0.001	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TCEB2—kidney cancer	3.73e-05	0.001	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ST3GAL2—kidney cancer	3.73e-05	0.001	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	3.68e-05	0.000987	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CCBL1—kidney cancer	3.66e-05	0.000982	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALDH1A1—kidney cancer	3.65e-05	0.000978	CbGpPWpGaD
Triamcinolone—Nausea—Doxorubicin—kidney cancer	3.59e-05	0.000189	CcSEcCtD
Triamcinolone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.53e-05	0.000947	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC5A3—kidney cancer	3.5e-05	0.000938	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PGK1—kidney cancer	3.5e-05	0.000938	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.49e-05	0.000936	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.48e-05	0.000933	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LDHB—kidney cancer	3.43e-05	0.00092	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GPC3—kidney cancer	3.31e-05	0.000889	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.31e-05	0.000888	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	3.3e-05	0.000885	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.19e-05	0.000856	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GLIPR1—kidney cancer	3.17e-05	0.000852	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPAT—kidney cancer	3.17e-05	0.000852	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—RAF1—kidney cancer	3.16e-05	0.000847	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.13e-05	0.000841	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.12e-05	0.000837	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.1e-05	0.000832	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ST3GAL2—kidney cancer	3.07e-05	0.000822	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—RPL14—kidney cancer	3.03e-05	0.000814	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.03e-05	0.000814	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CA9—kidney cancer	2.97e-05	0.000797	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	2.97e-05	0.000796	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APRT—kidney cancer	2.95e-05	0.000792	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FH—kidney cancer	2.95e-05	0.000792	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.94e-05	0.00079	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.91e-05	0.000781	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.9e-05	0.000779	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.88e-05	0.000774	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PGK1—kidney cancer	2.87e-05	0.000771	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC5A3—kidney cancer	2.87e-05	0.000771	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.83e-05	0.000758	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LDHB—kidney cancer	2.82e-05	0.000756	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SFRP2—kidney cancer	2.82e-05	0.000756	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF2—kidney cancer	2.8e-05	0.000752	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPC3—kidney cancer	2.77e-05	0.000744	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA2—kidney cancer	2.7e-05	0.000724	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.7e-05	0.000723	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALAD—kidney cancer	2.63e-05	0.000706	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TCEB2—kidney cancer	2.63e-05	0.000705	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TCEB1—kidney cancer	2.63e-05	0.000705	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.61e-05	0.0007	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.57e-05	0.000691	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.57e-05	0.00069	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.57e-05	0.000689	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.57e-05	0.000689	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.55e-05	0.000683	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CRABP1—kidney cancer	2.53e-05	0.000678	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.51e-05	0.000673	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.49e-05	0.000668	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.48e-05	0.000666	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.47e-05	0.000664	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HSPB1—kidney cancer	2.47e-05	0.000664	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PGK1—kidney cancer	2.41e-05	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A3—kidney cancer	2.41e-05	0.000645	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.4e-05	0.000643	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.37e-05	0.000635	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LDHB—kidney cancer	2.36e-05	0.000633	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ITPR2—kidney cancer	2.35e-05	0.00063	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PSMD7—kidney cancer	2.3e-05	0.000617	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.27e-05	0.00061	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.24e-05	0.000602	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.24e-05	0.000602	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MAPK1—kidney cancer	2.17e-05	0.000581	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.17e-05	0.000581	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ACHE—kidney cancer	2.14e-05	0.000575	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTT1—kidney cancer	2.14e-05	0.000575	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPL14—kidney cancer	2.14e-05	0.000573	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.12e-05	0.000569	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—JUNB—kidney cancer	2.06e-05	0.000554	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.06e-05	0.000554	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA9—kidney cancer	2.05e-05	0.000549	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SCARB1—kidney cancer	2.03e-05	0.000544	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.02e-05	0.000542	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS1—kidney cancer	2.01e-05	0.000539	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACY1—kidney cancer	2e-05	0.000537	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2e-05	0.000536	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PSMD7—kidney cancer	1.97e-05	0.000528	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ITPR2—kidney cancer	1.93e-05	0.000518	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.91e-05	0.000512	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—kidney cancer	1.87e-05	0.000502	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC5A5—kidney cancer	1.84e-05	0.000495	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC2A1—kidney cancer	1.78e-05	0.000478	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.75e-05	0.00047	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CRABP1—kidney cancer	1.74e-05	0.000467	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.73e-05	0.000463	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PDHB—kidney cancer	1.7e-05	0.000456	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.7e-05	0.000455	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.69e-05	0.000455	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.68e-05	0.000451	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSMD7—kidney cancer	1.62e-05	0.000434	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ITPR2—kidney cancer	1.62e-05	0.000434	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.6e-05	0.000429	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.51e-05	0.000404	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.49e-05	0.0004	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTP1—kidney cancer	1.48e-05	0.000398	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTT1—kidney cancer	1.47e-05	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ACHE—kidney cancer	1.47e-05	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC2A1—kidney cancer	1.46e-05	0.000393	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JUNB—kidney cancer	1.45e-05	0.00039	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCB1—kidney cancer	1.41e-05	0.000377	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SCARB1—kidney cancer	1.4e-05	0.000374	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.39e-05	0.000372	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPAT—kidney cancer	1.39e-05	0.000372	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTGS1—kidney cancer	1.38e-05	0.000371	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—kidney cancer	1.36e-05	0.000366	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PSMD7—kidney cancer	1.36e-05	0.000364	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.35e-05	0.000363	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.34e-05	0.000358	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A1—kidney cancer	1.29e-05	0.000347	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APRT—kidney cancer	1.29e-05	0.000346	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FH—kidney cancer	1.29e-05	0.000346	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCHE—kidney cancer	1.28e-05	0.000345	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A5—kidney cancer	1.27e-05	0.00034	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC2A1—kidney cancer	1.23e-05	0.000329	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPC3—kidney cancer	1.21e-05	0.000325	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN2B—kidney cancer	1.18e-05	0.000317	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA2—kidney cancer	1.18e-05	0.000316	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALAD—kidney cancer	1.15e-05	0.000308	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.12e-05	0.000301	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.1e-05	0.000294	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.06e-05	0.000285	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.05e-05	0.000282	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PGK1—kidney cancer	1.05e-05	0.000282	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.04e-05	0.000278	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LDHB—kidney cancer	1.03e-05	0.000276	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000274	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCB1—kidney cancer	9.68e-06	0.00026	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—kidney cancer	9.65e-06	0.000259	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIF1A—kidney cancer	9.45e-06	0.000254	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TSC2—kidney cancer	9.43e-06	0.000253	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—kidney cancer	9.39e-06	0.000252	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA9—kidney cancer	8.93e-06	0.00024	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A1—kidney cancer	8.9e-06	0.000239	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KIT—kidney cancer	8.33e-06	0.000223	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APC—kidney cancer	8.33e-06	0.000223	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BRAF—kidney cancer	7.83e-06	0.00021	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—kidney cancer	7.69e-06	0.000206	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CRABP1—kidney cancer	7.6e-06	0.000204	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.32e-06	0.000196	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ITPR2—kidney cancer	7.06e-06	0.000189	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—kidney cancer	6.71e-06	0.00018	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK3—kidney cancer	6.7e-06	0.00018	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—kidney cancer	6.64e-06	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RAF1—kidney cancer	6.54e-06	0.000175	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—kidney cancer	6.51e-06	0.000175	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB2—kidney cancer	6.47e-06	0.000173	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACHE—kidney cancer	6.44e-06	0.000173	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTT1—kidney cancer	6.44e-06	0.000173	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTOR—kidney cancer	6.38e-06	0.000171	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD4—kidney cancer	6.37e-06	0.000171	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SCARB1—kidney cancer	6.1e-06	0.000164	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS1—kidney cancer	6.03e-06	0.000162	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1B—kidney cancer	5.99e-06	0.000161	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PSMD7—kidney cancer	5.92e-06	0.000159	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—kidney cancer	5.66e-06	0.000152	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCHE—kidney cancer	5.61e-06	0.000151	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.54e-06	0.000149	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—kidney cancer	5.51e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.35e-06	0.000144	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—kidney cancer	4.73e-06	0.000127	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK3—kidney cancer	4.71e-06	0.000126	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—kidney cancer	4.62e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—kidney cancer	4.58e-06	0.000123	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK1—kidney cancer	4.48e-06	0.00012	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—kidney cancer	4.46e-06	0.00012	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—kidney cancer	4.23e-06	0.000114	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCB1—kidney cancer	4.23e-06	0.000113	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—kidney cancer	4.1e-06	0.00011	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—kidney cancer	3.89e-06	0.000104	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.89e-06	0.000104	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—kidney cancer	3.26e-06	8.74e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—kidney cancer	2.9e-06	7.78e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.31e-06	6.2e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—kidney cancer	2.02e-06	5.41e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.42e-06	3.82e-05	CbGpPWpGaD
